GlassScriptPhysician profile
Michelle Pearlman
NPI 1649533688
$5,178.11
in general payments reported to CMS, 2019-2025
7 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $732 · 2024: $4,213 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,043 · Food and Beverage: $1,103 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,042.50 |
| Food and Beverage | $1,103.34 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Marius Pharmaceuticals, INC | $4,042.50 | 2024 | |
| Lumenis Be INC | $526.85 | 2023 | M22 |
| Novo Nordisk INC | $429.87 | 2023-2025 | Wegovy |
| Endo USA, INC. | $76.26 | 2025 | Xiaflex |
| Intercept Pharmaceuticals, INC. | $42.47 | 2023 | Ocaliva |
| Endo Pharmaceuticals INC. | $41.54 | 2024 | Xiaflex |
| Lilly USA, LLC | $18.62 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Pearlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.